Analyst Consensus ?
ConsensusHold44 ratings
Bullish1943.2%
Neutral2454.5%
Bearish12.3%
FN2 Earnings Intelligence
The Allstate Corporation analyst ratings
The Allstate Corporation (ALL) analyst consensus, price targets, and firm-level rating history from FN2 Research.
Analyst 52W Price Targets
$274.37Current
$119Low
$223.93Average
$319High
Latest persisted target per named analyst; persisted current price from FN2's market snapshot as of Jul 29, 2026. Not an FN2 forecast.
Firm-level rating actions
FMP grade actions identify the grading firm, not a named analyst.
| Firm | Rating | Prior rating | Action | Date |
|---|---|---|---|---|
| UBS | Neutral | Buy | Downgrade | Jul 15, 2026 |
| JP Morgan | Overweight | Overweight | Maintain | Jul 14, 2026 |
| Evercore ISI Group | Outperform | Outperform | Maintain | Jul 10, 2026 |
| Mizuho | Outperform | Outperform | Maintain | Jul 9, 2026 |
| Cantor Fitzgerald | Neutral | Neutral | Maintain | Jul 9, 2026 |
| Keefe, Bruyette & Woods | Market Perform | Market Perform | Maintain | Jul 8, 2026 |
| Barclays | Underweight | Underweight | Maintain | Jul 7, 2026 |
| Raymond James | Strong Buy | Strong Buy | Maintain | Jul 6, 2026 |
| Morgan Stanley | Equal Weight | Equal Weight | Maintain | Jul 6, 2026 |
| HSBC | Hold | Buy | Downgrade | Jul 6, 2026 |
| Wells Fargo | Equal Weight | Equal Weight | Maintain | May 6, 2026 |
| Piper Sandler | Overweight | Overweight | Maintain | May 1, 2026 |
| Citigroup | Neutral | Neutral | Maintain | May 1, 2026 |
| TD Cowen | Hold | Buy | Downgrade | Jan 12, 2026 |
| William Blair | Market Perform | Outperform | Downgrade | Dec 18, 2025 |
| Roth Capital | Buy | Buy | Maintain | Nov 26, 2025 |
| BMO Capital | Outperform | Outperform | Maintain | Nov 7, 2025 |
| Jefferies | Buy | Buy | Maintain | Aug 11, 2025 |
| Goldman Sachs | Buy | Buy | Maintain | Nov 15, 2024 |
| B of A Securities | Buy | Buy | Maintain | Oct 18, 2024 |
| Roth MKM | Buy | Buy | Maintain | Aug 14, 2024 |
| CFRA | Hold | Buy | Downgrade | Oct 21, 2022 |
| MKM Partners | Buy | Buy | Maintain | Oct 20, 2022 |
| Argus Research | Hold | Buy | Downgrade | May 20, 2022 |
| Credit Suisse | Outperform | Outperform | Maintain | Apr 28, 2022 |
| Wolfe Research | Perform | Peer Perform | Maintain | Aug 17, 2021 |
| Deutsche Bank | Hold | Hold | Maintain | May 13, 2021 |
| Buckingham Research | Neutral | Neutral | Maintain | Sep 12, 2019 |
| Buckingham | Neutral | Neutral | Maintain | Sep 12, 2019 |
| Compass Point | Buy | Buy | Maintain | Jan 15, 2019 |
| B. Riley Securities | Neutral | Neutral | Maintain | Aug 7, 2018 |
| B. Riley FBR | Neutral | Neutral | Maintain | Aug 7, 2018 |
| Argus | Buy | Buy | Maintain | May 9, 2018 |
| Keefe Bruyette & Woods | Market Perform | Underperform | Upgrade | Apr 2, 2018 |
| Bank of America | Buy | Buy | Maintain | Feb 8, 2018 |
| Macquarie | Neutral | Outperform | Downgrade | Apr 19, 2017 |
| Nomura | Neutral | Neutral | Maintain | Feb 4, 2016 |
| PiperJaffray | Overweight | Overweight | Maintain | Oct 15, 2015 |
| Sandler O'Neill | Buy | Hold | Upgrade | Sep 21, 2015 |
| RBC Capital | Sector Perform | Outperform | Downgrade | Aug 4, 2015 |
| FBR Capital | Market Perform | Market Perform | Maintain | Oct 1, 2014 |
| Guggenheim | Buy | Buy | Maintain | Sep 18, 2013 |
| SunTrust Robinson Humphrey | Neutral | Neutral | Maintain | Sep 27, 2012 |
| Drexel Hamilton | Hold | Hold | Maintain | Aug 1, 2012 |
Named analyst price targets
Upside is calculated against the persisted current price $274.37. FMP does not supply a rating on these named-analyst rows.
| Firm | Analyst | 52W target | Price when posted | Upside | Date |
|---|---|---|---|---|---|
| Roth Capital | Analyst unavailable | $275 | $248.55 | +0.2% | Jul 17, 2026 |
| Atlantic Equities | Analyst unavailable | $319 | $240.55 | +16.3% | Jul 15, 2026 |
| UBS | Analyst unavailable | $261 | $250.35 | -4.9% | Jul 15, 2026 |
| Evercore ISI | David Motemaden | $240 | $250.59 | -12.5% | Jul 10, 2026 |
| Cantor Fitzgerald | Ryan Tunis | $242 | $249.27 | -11.8% | Jul 9, 2026 |
| Mizuho Securities | Analyst unavailable | $272 | $251.17 | -0.9% | Jul 9, 2026 |
| Barclays | Alex Scott | $213 | $248.37 | -22.4% | Jul 7, 2026 |
| Raymond James | Analyst unavailable | $300 | $248.04 | +9.3% | Jul 6, 2026 |
| Morgan Stanley | Bob Huang | $240 | $250.33 | -12.5% | Jul 6, 2026 |
| HSBC | Vikram Gandhi | $264 | $250.33 | -3.8% | Jul 6, 2026 |
| Piper Sandler | Analyst unavailable | $268 | $217.26 | -2.3% | May 1, 2026 |
| Raymond James | Gregory Peters | $260 | $213.61 | -5.2% | Mar 3, 2026 |
| Mizuho Securities | Analyst unavailable | $281 | $207.55 | +2.4% | Feb 9, 2026 |
| Goldman Sachs | Analyst unavailable | $238 | $207.55 | -13.3% | Feb 7, 2026 |
| Wells Fargo | Elyse Greenspan | $228 | $212.13 | -16.9% | Feb 6, 2026 |
| Mizuho Securities | Analyst unavailable | $255 | $197.65 | -7.1% | Jan 14, 2026 |
| Wells Fargo | Analyst unavailable | $223 | $208.66 | -18.7% | Jan 13, 2026 |
| Goldman Sachs | Analyst unavailable | $227 | $207.27 | -17.3% | Jan 7, 2026 |
| Evercore ISI | Analyst unavailable | $225 | $208.97 | -18.0% | Jan 7, 2026 |
| Morgan Stanley | Bob Huang | $215 | $211.69 | -21.6% | Dec 16, 2025 |
| Mizuho Securities | Yaron Kinar | $254 | $211.69 | -7.4% | Dec 15, 2025 |
| Roth Capital | Harry Fong | $240 | $212.65 | -12.5% | Nov 26, 2025 |
| UBS | Analyst unavailable | $250 | $213.06 | -8.9% | Oct 8, 2025 |
| Evercore ISI | David Motemaden | $233 | $214.65 | -15.1% | Oct 1, 2025 |
| Roth Capital | Analyst unavailable | $230 | $209.82 | -16.2% | Sep 26, 2025 |
| Wells Fargo | Analyst unavailable | $202 | $205.55 | -26.4% | Aug 5, 2025 |
| Barclays | Alex Scott | $198 | $192.28 | -27.8% | Jul 31, 2025 |
| Wells Fargo | Elyse Greenspan | $197 | $200.17 | -28.2% | May 6, 2025 |
| Raymond James | Gregory Peters | $250 | $200.25 | -8.9% | May 5, 2025 |
| Wells Fargo | Elyse Greenspan | $187 | $186.04 | -31.8% | Jan 14, 2025 |
| BMO Capital | Michael Zaremski | $214 | $195.51 | -22.0% | Oct 18, 2024 |
| Bank of America Securities | Joshua Shanker | $233 | $195.51 | -15.1% | Oct 18, 2024 |
| Bank of America Securities | Joshua Shanker | $216 | $184.91 | -21.3% | Oct 10, 2024 |
| Raymond James | Gregory Peters | $220 | $187.84 | -19.8% | Oct 4, 2024 |
| Wells Fargo | Elyse Greenspan | $175 | $178.11 | -36.2% | Aug 16, 2024 |
| Piper Sandler | Paul Newsome | $196 | $178.11 | -28.6% | Aug 16, 2024 |
| CFRA | Catherine Seifert | $200 | $180.95 | -27.1% | Aug 14, 2024 |
| Wells Fargo | Elyse Greenspan | $177 | $171.03 | -35.5% | Aug 12, 2024 |
| Jefferies | Yaron Kinar | $217 | $169.02 | -20.9% | Aug 5, 2024 |
| BMO Capital | Michael Zaremski | $205 | $176.82 | -25.3% | Aug 5, 2024 |
| BMO Capital | Michael Zaremski | $191 | $176.69 | -30.4% | Jul 18, 2024 |
| Piper Sandler | Paul Newsome | $188 | $173.01 | -31.5% | Apr 1, 2024 |
| HSBC | Vikram Gandhi | $190 | $169.84 | -30.8% | Mar 28, 2024 |
| Wells Fargo | Analyst unavailable | $104 | $131.68 | -62.1% | Feb 3, 2023 |
| Evercore ISI | Analyst unavailable | $138 | $131.53 | -49.7% | Feb 2, 2023 |
| Piper Sandler | Analyst unavailable | $153 | $140.01 | -44.2% | Jan 10, 2023 |
| Goldman Sachs | Analyst unavailable | $166 | $140.36 | -39.5% | Jan 9, 2023 |
| Morgan Stanley | Analyst unavailable | $137 | $134.26 | -50.1% | Nov 22, 2022 |
| Credit Suisse | Andrew Kligerman | $188 | $121.39 | -31.5% | Sep 2, 2022 |
| Morgan Stanley | Analyst unavailable | $140 | $131.18 | -49.0% | Aug 19, 2022 |
| Piper Sandler | Analyst unavailable | $147 | $141.13 | -46.4% | Apr 22, 2022 |
| Raymond James | Gregory Peters | $165 | $141.8 | -39.9% | Mar 27, 2022 |
| Raymond James | Gregory Peters | $145 | $125.88 | -47.2% | Mar 14, 2022 |
| Goldman Sachs | Alex Scott | $142 | $125.68 | -48.2% | Mar 3, 2022 |
| Jefferies | Yaron Kinar | $122 | $121.54 | -55.5% | Jan 6, 2022 |
| Barclays | Tracy Benguigui | $119 | $121.54 | -56.6% | Jan 6, 2022 |
| Deutsche Bank | Phil Stefano | $131 | $134 | -52.3% | May 13, 2021 |
| Argus Research | Kevin Heal | $155 | $131.05 | -43.5% | May 10, 2021 |
Track every rating change on ALL the moment it posts. Free to start.
Start free